CHINA PHARMA HOLDINGS, INC. Receivable with Imputed Interest, Net Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) had Receivable with Imputed Interest, Net Amount of $5.70 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Receivables › and Others
us-gaap:ReceivableWithImputedInterestNetAmount · last filed 2023-08-14
- 2023-06-30: Receivable with Imputed Interest, Net Amount $5.70K.
- 2023-03-31: Receivable with Imputed Interest, Net Amount $164.00.
- 2022-12-31: Receivable with Imputed Interest, Net Amount $562.00.
- 2022-09-30: Receivable with Imputed Interest, Net Amount $1.18K.
| Period end | Receivable with Imputed Interest, Net Amount |
|---|---|
| 2023-06-30 | $5.70K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $164.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $562.00 10-K · filed 2023-03-30 |
| 2022-09-30 | $1.18K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.15K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.48K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.92K 10-K · filed 2022-03-30 |
| 2021-09-30 | $6.51K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $8.46K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $223.00 10-Q · filed 2021-05-14 |
| 2020-12-31 | $744.00 10-K · filed 2021-03-26 |
| 2020-09-30 | $1.49K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.46K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.74K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $5.38K 10-K · filed 2020-03-30 |
| 2019-09-30 | $7.11K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $9.45K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $12.13K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |